- Patients with non-small cell lung cancer harboring ALK receptor tyrosine kinase ( ALK), ROS proto-oncogene 1 ( ROS1), and ret proto-oncogene ( RET) gene rearrangements can benefit from specific kinase inhibitors. Detection of fusion genes is critical for determining the best treatment. Assessing rearrangements in non-small cell lung cancer remains challenging, particularly for lung cytology.

Analysis of Fusion Genes by NanoString System: A Role in Lung Cytology?

Alì, Greta;Bruno, Rossella;Giannini, Riccardo;Boldrini, Laura;Proietti, Agnese;Ribechini, Alessandro;Fontanini, Gabriella
2018

Abstract

- Patients with non-small cell lung cancer harboring ALK receptor tyrosine kinase ( ALK), ROS proto-oncogene 1 ( ROS1), and ret proto-oncogene ( RET) gene rearrangements can benefit from specific kinase inhibitors. Detection of fusion genes is critical for determining the best treatment. Assessing rearrangements in non-small cell lung cancer remains challenging, particularly for lung cytology.
Alì, Greta; Bruno, Rossella; Savino, Mauro; Giannini, Riccardo; Pelliccioni, Serena; Menghi, Maura; Boldrini, Laura; Proietti, Agnese; Chella, Antonio; Ribechini, Alessandro; Fontanini, Gabriella
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/917114
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 30
  • ???jsp.display-item.citation.isi??? 26
social impact